incorporating ibd biosimilars into practice: patient care and education
Published 4 years ago • 370 plays • Length 16:22Download video MP4
Download video MP3
Similar videos
-
20:40
patient care in ibd: incorporating biosimilars into clinical practice
-
18:23
biosimilars for ibd: to start, switch, or stay away?
-
10:00
ibd clinical case: the process of switching from a reference biologic to a biosimilar
-
16:48
biosimilars in ibd: where do we stand today?
-
45:20
biosimilar integration in the patient-centered medical home
-
1:02:17
integrating insulin biosimilars into clinical practice: new pathways and new challenges
-
16:44
the current landscape of biosimilars in ibd
-
13:19
what are biosimilar therapies and why should we care?
-
20:47
biosimilars for ibd: start, switch, or stay away?
-
11:40
debate: biosimilar therapies - caution, more studies are needed
-
21:14
when and how to use immunomodulators and biologics in ibd
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
2:13
understanding biosimilars - what ibd patients should know
-
1:47
understanding biosimilars - for ibd patients
-
4:04
biosimilars and inflammatory bowel disease
-
23:20
biosimilars for ibd: when to start, switch, or stay away?
-
16:47
what is needed and what is the role of biosimilars?
-
15:27
status of biosimilars in us & experience from asia & europe
-
1:07:38
understanding biosimilars: what ibd patients & caregivers need to know